Send this article to a friend Print the page 

viadeo-hemarina facebook-hemarina flux rss hemarina linked in hemarina


Dr Franck Zal, CEO of HEMARINA, wins the prize « Biotech d’avenir » Technology Fast 50 Western France organised par Deloitte In Extenso

Morlaix, Finistère – 8/11//2013 – HEMARINA, French based biotechnology company, is pleased to announce its co-founder, CEO and Chief Scientific Officer, Dr. Franck Zal is... More +

HEMARINA & LFB Biomanufacturing announced the signature of an agreement for the manufacturing of HEMO2life®

Morlaix, Finistère - 17/09/2013 – HEMARINA, entreprise française de biotechnologies, est très heureuse d'annoncer que son co-fondateur, directeur scientifique et PDG, le... More +

HEMARINA, ORPHY, the UBO laboratory, and the University Hospital (CHRU) of Brest launch HEMOXYCHOC, the preclinic project designed to assess the efficacy & safety of HEMOXYCarrier® in the management of uncontrolled hemorrhagic shock.

Morlaix, February 11th, 2014 - Hemorrhagic shock is the second leading cause of injury death after brain injuries. Such traumas lead to a reduction of patient oxygenation resulting from a... More +

Technology & Products
Intellectual Property
Investors News & Media

>> Company Overview
>> Managment Team
>> Board of Directors
>> Scientific and Ethics Board
>> Hemarina Label and Public Funding

>> Organ Preservation
>> Wound Healing
>> Hemoglobin Oxygen-Carrier
>> Cell Culture and  Bioproduction
>> Other Perspective

>> Portfolio
>> Literature References


>> News
Hemarina Awards
Press Releases
Video Releases
>> 2013